Avigya Bio

Hyderabad, India Founded: 2020 • Age: 6 yrs
Contract research organization for pharmaceutical intermediates and specialty chemicals.

About Avigya Bio

Avigya Bio is a Healthcare company based in Hyderabad (India) founded in 2020. Contract research organization for pharmaceutical intermediates and specialty chemicals. It operates on a B2B model. The company has 14 employees. Its Indian entity Avigya Biosciences Private Limited reported revenue of β‚Ή10.85 Cr. Avigya Bio offers products and services including Process Chemistry, Synthetic Chemistry, Specialized Chemistry, Cefpodoxime, and Cefixime. Its focus areas include Pharmaceuticals, Intermediates, Specialty Chemicals and Agriculture.

Company details

Avigya Biosciences Is A Hyderabad, India-based Company That Operates As A Contract Research Organization In The Pharmaceutical Sector. It Offers Services Like Process Chemistry, Synthetic Chemistry, And Specialized Chemistry To Domestic And International Customers. The Firm Focuses On Developing Intermediates, Specialty Chemicals, Impurities, And Active Pharmaceutical Ingredients With Capabilities From Mg To Multi-kg Scale. It Emphasizes Quality, Competitive Pricing, And Expertise In Rd And Manufacturing, Serving Clients In Pharmaceuticals And Agro Chemicals.

  • Headquarters Hyderabad, India
  • Employees 14
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website avigyabio.com
  • Legal Name Avigya Biosciences Private Limited
  • Date of Incorporation 13 Jun, 2020
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹10.85 Cr

    FY 2024 · +3% YoY

  • Net Profit
    ₹13.4 Lakh

    FY 2024 · 1% margin

  • EBITDA
    ₹50.4 Lakh

    FY 2024 · 5% margin

  • Employee Count
    14

Products & Services of Avigya Bio

Avigya Bio offers a comprehensive portfolio of products and services, including Process Chemistry, Synthetic Chemistry, Specialized Chemistry, Cefpodoxime, and Cefixime.

Process Chemistry
Research Service

Service for developing chemical processes in pharmaceuticals.

Synthetic Chemistry
Chemical Synthesis

Method for creating organic compounds for pharmaceutical use.

Specialized Chemistry
Advanced Research

Tailored chemical solutions for impurities and intermediates.

Cefpodoxime
Pharmaceutical Product

Intermediate for antibiotic production in medical applications.

Cefixime
Pharmaceutical Product

Chemical compound used as an active ingredient in antibiotics.

Board of directors of Avigya Biosciences Private Limited (Avigya Bio)

Avigya Biosciences Private Limited is the primary company behind Avigya Bio. The board of Avigya Biosciences Private Limited currently have 5 directors; the longest-serving is Ramakrishna Kamutam, appointed in 2020.

DirectorDesignationAppointedTenureEntity
Ramakrishna Kamutam
DIN 07340489
Director13 Jun 20206 yrs 5 moAvigya Biosciences Private Limited
Ravindar Kotla
DIN 08761751
Director13 Jun 20206 yrs 5 moAvigya Biosciences Private Limited
Radhika Gandam
DIN 08910513
Director11 Oct 20206 yrs 1 moAvigya Biosciences Private Limited
Mangalapally Jyothi
DIN 09081511
Director25 Feb 20215 yrs 8 moAvigya Biosciences Private Limited
Vijender Medamoni
DIN 01594109
Director23 Jan 20251 yr 9 moAvigya Biosciences Private Limited

Financials of Avigya Bio

Figures of Avigya Biosciences Private Limited, the primary company behind Avigya Bio, for FY 2024. Revenue was ₹10.85 Cr (+3% year on year). Net profit was ₹13.4 Lakh (1% margin). EBITDA was ₹50.4 Lakh (5% margin). Revenue has grown at a compounded annual rate of +142% over three years.

  • ₹10.85 CrRevenue · FY 2024 · +3% YoY
  • ₹13.4 LakhNet profit · 1% margin
  • ₹50.4 LakhEBITDA · 5% margin
  • ₹1.60 CrPaid-up capital
  • 14Employees (provident fund records)
  • +142%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Avigya Biosciences Private Limited are on its company page.

Premium access

Detailed financial statements for Avigya Bio

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Avigya Bio

Avigya Bio was founded in 2020.

Avigya Bio is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Avigya Bio has 14 employees.

The primary company behind Avigya Bio, Avigya Biosciences Private Limited, reported revenue of β‚Ή10.85 Cr for FY 2024, up 3% year on year.

Avigya Biosciences Is A Hyderabad, India-based Company That Operates As A Contract Research Organization In The Pharmaceutical Sector. It Offers Services Like Process Chemistry, Synthetic Chemistry, And Specialized Chemistry To Domestic And International Customers. The Firm Focuses On Developing Intermediates, Specialty Chemicals, Impurities, And Active Pharmaceutical Ingredients With Capabilities From Mg To Multi-kg Scale. It Emphasizes Quality, Competitive Pricing, And Expertise In Rd And Manufacturing, Serving Clients In Pharmaceuticals And Agro Chemicals.

Avigya Bio offers Process Chemistry, Synthetic Chemistry, Specialized Chemistry, Cefpodoxime, and Cefixime.

Avigya Bio operates through Avigya Biosciences Private Limited.

The legal entities of Avigya Bio currently have 5 directors, including Ramakrishna Kamutam, Radhika Gandam, Mangalapally Jyothi and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available